[DPHARMA] YoY TTM Result on 31-Mar-2014 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
20-May-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Mar-2014 [#1]
Profit Trend
QoQ- 4.98%
YoY- 35.17%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 354,464 304,911 182,065 165,062 137,091 141,205 135,625 17.34%
PBT 32,714 47,508 47,513 42,396 35,384 35,723 36,493 -1.80%
Tax -5,098 -9,864 -8,428 -7,243 -9,378 -8,233 -7,030 -5.21%
NP 27,616 37,644 39,085 35,153 26,006 27,490 29,463 -1.07%
-
NP to SH 27,890 37,659 36,283 35,153 26,006 27,490 29,463 -0.90%
-
Tax Rate 15.58% 20.76% 17.74% 17.08% 26.50% 23.05% 19.26% -
Total Cost 326,848 267,267 142,980 129,909 111,085 113,715 106,162 20.59%
-
Net Worth 463,071 457,740 205,045 190,050 176,143 170,824 162,320 19.07%
Dividend
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Div 19,142 5,682 25,682 24,289 19,431 24,987 6,402 20.00%
Div Payout % 68.64% 15.09% 70.79% 69.10% 74.72% 90.90% 21.73% -
Equity
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Net Worth 463,071 457,740 205,045 190,050 176,143 170,824 162,320 19.07%
NOSH 278,959 278,959 139,486 138,723 138,695 138,881 138,735 12.33%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 7.79% 12.35% 21.47% 21.30% 18.97% 19.47% 21.72% -
ROE 6.02% 8.23% 17.70% 18.50% 14.76% 16.09% 18.15% -
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 127.07 109.24 130.52 118.99 98.84 101.67 97.76 4.46%
EPS 10.00 13.49 26.01 25.34 18.75 19.79 21.24 -11.78%
DPS 6.86 2.04 18.50 17.50 14.00 18.00 4.61 6.84%
NAPS 1.66 1.64 1.47 1.37 1.27 1.23 1.17 5.99%
Adjusted Per Share Value based on latest NOSH - 138,723
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 36.85 31.70 18.93 17.16 14.25 14.68 14.10 17.34%
EPS 2.90 3.91 3.77 3.65 2.70 2.86 3.06 -0.89%
DPS 1.99 0.59 2.67 2.53 2.02 2.60 0.67 19.87%
NAPS 0.4814 0.4759 0.2132 0.1976 0.1831 0.1776 0.1687 19.07%
Price Multiplier on Financial Quarter End Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 -
Price 2.31 2.55 3.88 3.03 2.23 2.40 2.35 -
P/RPS 1.82 2.33 2.97 2.55 2.26 2.36 2.40 -4.50%
P/EPS 23.10 18.90 14.92 11.96 11.89 12.13 11.07 13.03%
EY 4.33 5.29 6.70 8.36 8.41 8.25 9.04 -11.53%
DY 2.97 0.80 4.77 5.78 6.28 7.50 1.96 7.16%
P/NAPS 1.39 1.55 2.64 2.21 1.76 1.95 2.01 -5.95%
Price Multiplier on Announcement Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 22/05/17 18/05/16 18/05/15 20/05/14 27/05/13 17/05/12 25/05/11 -
Price 2.32 2.40 3.90 3.09 2.51 2.38 2.57 -
P/RPS 1.83 2.20 2.99 2.60 2.54 2.34 2.63 -5.86%
P/EPS 23.20 17.79 14.99 12.19 13.39 12.02 12.10 11.44%
EY 4.31 5.62 6.67 8.20 7.47 8.32 8.26 -10.26%
DY 2.96 0.85 4.74 5.66 5.58 7.56 1.79 8.73%
P/NAPS 1.40 1.46 2.65 2.26 1.98 1.93 2.20 -7.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment